Nervenheilkunde 2014; 33(12): 855-857
DOI: 10.1055/s-0038-1627760
Bipolare Störungen
Schattauer GmbH

Bipolare Störungen im DSM-5 und ihre Praxisrelevanz

Bipolar disorders in DSM-5 and its relevance to clinical practice
E. Severus
1   Klinik für Psychiatrie und Psychotherapie des Carl Gustav Carus Universitätsklinikums der TU Dresden, Dresden
,
A. Pfennig
1   Klinik für Psychiatrie und Psychotherapie des Carl Gustav Carus Universitätsklinikums der TU Dresden, Dresden
,
P. Ritter
1   Klinik für Psychiatrie und Psychotherapie des Carl Gustav Carus Universitätsklinikums der TU Dresden, Dresden
,
K. Leopold
1   Klinik für Psychiatrie und Psychotherapie des Carl Gustav Carus Universitätsklinikums der TU Dresden, Dresden
,
M. Bauer
1   Klinik für Psychiatrie und Psychotherapie des Carl Gustav Carus Universitätsklinikums der TU Dresden, Dresden
› Institutsangaben
Weitere Informationen

Publikationsverlauf

eingegangen am: 01. September 2014

angenommen am: 15. September 2015

Publikationsdatum:
22. Januar 2018 (online)

Zusammenfassung

DSM-5 wartet mit interessanten Veränderungen die Diagnose bipolarer Störungen betreffend auf. Während einige dieser Änderungen offenkundig Sinn machen, ist dies für andere schwerer vorherzusagen, besonders mit Hinblick auf ihre Praxisrelevanz. Dieser Artikel wird diese Änderungen kritisch betrachten und diskutieren.

Summary

DSM-5 brings along some interesting changes concerning the diagnosis of bipolar disorders. While some of these changes apparently make sense, this is more difficult to predict for others, in particular with respect to their clinical relevance. This article will point to these changes and critically discuss them.

 
  • Literatur

  • 1 Bauer M, Maier W, Schneider F, Kapfhammer HP. [The new DSM 5 classification system: essential amendments in the psychiatric classification]. Nervenarzt 2014; 85 (05) 531-2.
  • 2 Severus E, Bauer M. Bipolar disorders in DSM-5. Nervenarzt 2014; 85 (05) 543-7.
  • 3 Severus E, Bauer M. Diagnosing bipolar disorders in DSM-5. International. Journal of Bipolar Disorders. 2013 01. (14)
  • 4 Leopold K, Pfennig A, Severus E, Bauer M. [Prevention of bipolar disorders]. Nervenarzt 2013; 84 (11) 1310-5.
  • 5 Leopold K. et al. Risk constellations prior to the development of bipolar disorders: rationale of a new risk assessment tool. J Affect Disord 2012; 136 (03) 1000-10.
  • 6 Bauer M. et al. Self-reported data from patients with bipolar disorder: impact on minimum episode length for hypomania. J Affect Disord 2006; 96 (1–2): 101-5.
  • 7 Bschor T. et al. Time experience and time judgment in major depression, mania and healthy subjects. A controlled study of 93 subjects. Acta Psychiatr Scand 2004; 109 (03) 222-9.
  • 8 Severus E, Bauer M. The impact of treatment decisions on diagnosis of bipolar and related disorders. International Journal of Bipolar Disorders. 2014
  • 9 Frances A, Jones KD. Bipolar disorder type II revisited. Bipolar Disord 2012; 14 (05) 474-7.
  • 10 Zimmerman M. Broadening the concept of bipolar disorder: what should be done in the face of uncertainty?. World Psychiatry 2011; 10 (03) 188-9.
  • 11 Zimmerman M. Would broadening the diagnostic criteria for bipolar disorder do more harm than good? Implications from longitudinal studies of subthreshold conditions. J Clin Psychiatry 2012; 73 (04) 437-43.
  • 12 Severus E. Are bipolar disorders much more common than previously assumed? Against. Nervenarzt 2012; 83 (07) 904-6.
  • 13 Kernberg OF, Yeomans FE. Borderline personality disorder, bipolar disorder, depression, attention deficit/hyperactivity disorder, and narcissistic personality disorder: Practical differential diagnosis. Bull Menninger Clin 2013; 77 (01) 1-22.
  • 14 Zimmerman M, Martinez JH, Morgan TA, Young D, Chelminski I, Dalrymple K. Distinguishing bipolar II depression from major depressive disorder with comorbid borderline personality disorder: demographic, clinical, and family history differences. J Clin Psychiatry 2013; 74 (09) 880-6.
  • 15 Do EK, Mezuk B. Comorbidity between hypomania and substance use disorders. J Affect Disord 2013; 150 (03) 974-80.
  • 16 Pfennig A. et al. [S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations]. Nervenarzt 2012; 83 (05) 568-86.
  • 17 DeFife JA, Peart J, Bradley B, Ressler K, Drill R, Westen D. Validity of prototype diagnosis for mood and anxiety disorders. JAMA Psychiatry 2013; 70 (02) 140-8.
  • 18 Nassir GS, Miller CJ, Berv DA, Klugman J, Rosenquist KJ, Pies RW. Sensitivity and specificity of a new bipolar spectrum diagnostic scale. J Affect Disord 2005; 84 (2–3): 273-7.
  • 19 Hergueta T, Weiller E. Evaluating depressive symptoms in hypomanic and manic episodes using a structured diagnostic tool: validation of a new Mini International Neuropsychiatric Interview (M.I.N.I.) module for the DSM-5 ‘With Mixed Features’ specifier. International Journal of Bipolar Disorders. 2013 01. (21)
  • 20 Goldberg D, Fawcett J. The importance of anxiety in both major depression and bipolar disorder. Depress Anxiety 2012; 29 (06) 471-8.